Cancer and the tumor microenvironment: a review of an essential relationship

被引:558
作者
Mbeunkui, Flaubert [1 ]
Johann, Donald J., Jr. [2 ]
机构
[1] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA
[2] NCI, Ctr Canc Res, Med Oncol Branch, NIH, Bethesda, MD 20892 USA
关键词
Tumor; Microenvironment; Secreted proteins; Extracellular matrix; Molecular targets; Therapy; ENDOTHELIAL GROWTH-FACTOR; FIBROBLAST ACTIVATION PROTEIN; MAMMARY EPITHELIAL-CELLS; CODED AFFINITY TAGS; BREAST-CANCER; PROTEOMIC ANALYSIS; EXTRACELLULAR-MATRIX; SECRETED BIOMARKERS; COLORECTAL-CANCER; DRUG-RESISTANCE;
D O I
10.1007/s00280-008-0881-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose The role of the microenvironment during the initiation and progression of carcinogenesis is now realized to be of critical importance, both for enhanced understanding of fundamental cancer biology, as well as exploiting this source of relatively new knowledge for improved molecular diagnostics and therapeutics. Methods This review focuses on: (1) the approaches of preparing and analyzing secreted proteins, (2) the contribution of tumor microenvironment elements in cancer, and (3) the potential molecular targets for cancer therapy. Results The microenvironment of a tumor is an integral part of its physiology, structure, and function. It is an essential aspect of the tumor proper, since it supplies a nurturing environment for the malignant process. A fundamental deranged relationship between tumor and stromal cells is essential for tumor cell growth, progression, and development of life threatening metastasis. Improved understanding of this interaction may provide new and valuable clinical targets for cancer management, as well as risk assessment and prevention. Non-malignant cells and secreted proteins from tumor and stromal cells are active participants in cancer progression. Conclusions Monitoring the change in the tumor microenvironment via molecular and cellular profiles as tumor progresses would be vital for identifying cell or protein targets for cancer prevention and therapy.
引用
收藏
页码:571 / 582
页数:12
相关论文
共 104 条
[1]
The tumour microenvironment as a target for chemoprevention [J].
Albini, Adriana ;
Sporn, Michael B. .
NATURE REVIEWS CANCER, 2007, 7 (02) :139-147
[2]
Molecular characterization of the tumor microenvironment in breast cancer [J].
Allinen, M ;
Beroukhim, R ;
Cai, L ;
Brennan, C ;
Lahti-Domenici, J ;
Huang, HY ;
Porter, D ;
Hu, M ;
Chin, L ;
Richardson, A ;
Schnitt, S ;
Sellers, WR ;
Polyak, K .
CANCER CELL, 2004, 6 (01) :17-32
[3]
AMANCHY R, 2005, SCI STKE, P12
[4]
[Anonymous], 2007, BIOL CANC
[5]
Timeline - The evolution of thalidomide and its IMiD derivatives as anticancer agents [J].
Bartlett, JB ;
Dredge, K ;
Dalgleish, AG .
NATURE REVIEWS CANCER, 2004, 4 (04) :314-322
[6]
Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention [J].
Bertl, E ;
Bartsch, H ;
Gerhäuser, C .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (03) :575-585
[7]
TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia [J].
Bhowmick, NA ;
Chytil, A ;
Plieth, D ;
Gorska, AE ;
Dumont, N ;
Shappell, S ;
Washington, MK ;
Neilson, EG ;
Moses, HL .
SCIENCE, 2004, 303 (5659) :848-851
[8]
Burke PA, 2002, CANCER RES, V62, P4263
[9]
Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[10]
Toward a better analysis of secreted proteins: the example of the myeloid cells secretome [J].
Chevallet, Mireille ;
Diemer, Helene ;
Van Dorssealer, Alain ;
Villiers, Christian ;
Rabilloud, Thierry .
PROTEOMICS, 2007, 7 (11) :1757-1770